Danaher Extends Offer for Beckman Coulter | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danaher announced late on Tuesday that it has extended its offer to buy Beckman Coulter to expire at midnight EDT April 27.

The offer had been set to expire at midnight EDT today. All other terms and conditions of Danaher's $6.8 billion bid for Beckman Coulter are unchanged.

The deal is expected to close during the second quarter, Danaher said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.